Blackstone to Invest Up to $250 Million in Autolus Therapeutics of U.K.

Blackstone Inc. is investing as quite a bit as $250 million in U.Okay. biotechnology agency Autolus Therapeutics PLC to fund the last word ranges of enchancment of a model new treatment to cope with a crucial kind of leukemia, the companies talked about.

Of the entire funding, as quite a bit as $150 million will help the occasion and commercialization of obecabtagene autoleucel, a cell treatment that targets a scenario known as acute lymphoblastic leukemia. London-based Autolus will get hold of $50 million of that upfront, with the rest to be paid as the company achieves positive milestones. In return, Blackstone’s life-sciences unit will get hold of a portion of the treatment’s royalties. | Blackstone to Make investments As a lot as $250 Million in Autolus Therapeutics of U.Okay.

Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button